Myasthenia gravis laboratory findings: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{CMG}} {{Myasthenia gravis}} ==Laboratory Findings== ===Blood tests=== If the diagnosis is suspected, serology can be performed in a blood test to identify...")
 
No edit summary
Line 13: Line 13:
The "edrophonium test" is infrequently performed to identify MG; its application is limited to the situation when other investigations do not yield a conclusive diagnosis. This test requires the [[intravenous]] administration of [[edrophonium|edrophonium chloride]] (Tensilon®, Reversol®), a drug that blocks the breakdown of acetylcholine by [[cholinesterase]] and temporarily increases the levels of acetylcholine at the [[neuromuscular junction]]. In people with myasthenia gravis involving the eye muscles, edrophonium chloride will briefly relieve weakness.
The "edrophonium test" is infrequently performed to identify MG; its application is limited to the situation when other investigations do not yield a conclusive diagnosis. This test requires the [[intravenous]] administration of [[edrophonium|edrophonium chloride]] (Tensilon®, Reversol®), a drug that blocks the breakdown of acetylcholine by [[cholinesterase]] and temporarily increases the levels of acetylcholine at the [[neuromuscular junction]]. In people with myasthenia gravis involving the eye muscles, edrophonium chloride will briefly relieve weakness.


==Reference==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Needs content]]
[[Category:Rheumatology]]
[[Category:Neurology]]
[[Category:Rheumatology]]
{{WH}}
{{WS}}

Revision as of 14:07, 29 June 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Myasthenia gravis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Myasthenia Gravis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myasthenia gravis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myasthenia gravis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myasthenia gravis laboratory findings

CDC on Myasthenia gravis laboratory findings

Myasthenia gravis laboratory findings in the news

Blogs on Myasthenia gravis laboratory findings

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Myasthenia gravis laboratory findings

Laboratory Findings

Blood tests

If the diagnosis is suspected, serology can be performed in a blood test to identify antibodies against the acetylcholine receptor. The test has a reasonable sensitivity of 80–96%, but in MG limited to the eye muscles (ocular myasthenia) the test may be negative in up to 50% of the cases. About half of the patients without antibodies against the acetylcholine receptor have antibodies against the MuSK protein. In specific situations (decreased reflexes which increase on facilitation, co-existing autonomic features, suspected presence of neoplasm, presence of increment or facilitation on repetitive EMG testing) testing is performed for Lambert-Eaton syndrome, in which other antibodies (against a voltage-gated calcium channel) can be found.

Neurophysiology

Muscle fibers of patients with MG are easily fatigued, and thus do not respond as well as muscles in healthy individuals to repeated stimulation. By repeatedly stimulating a muscle with electrical impulses, the fatiguability of the muscle can be measured. This is called the repetitive nerve stimulation test. In single fiber electromyography, which is considered to be the most sensitive (although not the most specific) test for MG, a thin needle electrode is inserted into a muscle to record the electric potentials of individual muscle fibers. By finding two muscle fibers belonging to the same motor unit and measuring the temporal variability in their firing patterns (i.e. their 'jitter'), the diagnosis can be made.

Edrophonium test

The "edrophonium test" is infrequently performed to identify MG; its application is limited to the situation when other investigations do not yield a conclusive diagnosis. This test requires the intravenous administration of edrophonium chloride (Tensilon®, Reversol®), a drug that blocks the breakdown of acetylcholine by cholinesterase and temporarily increases the levels of acetylcholine at the neuromuscular junction. In people with myasthenia gravis involving the eye muscles, edrophonium chloride will briefly relieve weakness.

References

Template:WH Template:WS